251 results
Page 11 of 13
8-K
EX-99.1
lvwah1x12y
9 Mar 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
zb1dsj1p44tm
24 Feb 15
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
8dtuzfeq8p
29 Oct 14
Alkermes PLC Reports Third Quarter 2014 Financial Results
12:00am
8-K
EX-99.1
m7hafj0vf3vdbzf9ttu
31 Jul 14
Alkermes PLC Reports Second Quarter 2014 Financial Results
12:00am
8-K
EX-99.1
ztu21l8e2vl
8 Apr 14
Alkermes Announces Positive Topline Results from Pivotal Phase 3 Study of Aripiprazole Lauroxil for Treatment of Schizophrenia
12:00am
8-K
EX-99.1
wk0zfewylqj6
27 Feb 14
Results of Operations and Financial Condition
12:00am
10-KT
5tg 57g2kc7j1bqowc
27 Feb 14
Annual report (with FYE transition)
12:00am
8-K
EX-5.1
sbupd
16 Jan 14
Other Events
12:00am
424B5
opzxq1 m8z
13 Jan 14
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
2d0xtczp935gw 2nf
13 Jan 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
lxyqnwbu
8 Jan 14
Alkermes Announces Advances with Its Late-stage CNS Pipeline
12:00am
8-K
EX-99.1
kq5tr8h
6 Jan 14
Alkermes Announces Notice of Allowance of U.S. Patent for a Novel Fumarate Prodrug for Multiple Sclerosis
12:00am
8-K
EX-99.1
wqqs8 dkcgegmuslhb1
31 Oct 13
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
be65dl 0v7n8kk
25 Jul 13
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
2y556pculx8k4sc
23 May 13
Alkermes PLC Reports Financial Results for Fiscal Year 2013 and Provides Financial Expectations
12:00am